Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Enzyme-triggered in situ chromogenic and/or fluorogenic reactions under accessible conditions are significant for developing enzyme activity and related spectroscopic assays. Here, we describe a facile one-pot synthetic strategy to prepare silicon-containing nanoparticles with yellow-green fluorescence and orange-red color by mixing
N
-[3-(trimethoxysilyl)propyl]ethylenediamine and
p
-aminophenol (AP) in aqueous solution at a mild temperature. Encouraged by the AP-regulated simple synthetic procedure and the generation of AP from
alkaline phosphatase
(
ALP
)-catalyzed hydrolysis of
4-aminophenol
phosphate (APP), a fluorometric and colorimetric dual-readout
ALP
activity assay can be rationally envisioned and developed by employing APP as the substrate. In the wake of the good analytical performance of such
ALP
activity assay and its successful combination with enzyme-linked immunosorbent assay (ELISA), corresponding fluorometric and colorimetric dual-readout
ALP
-based ELISA has been constructed for highly sensitive and quantitative determination of human prostate-specific antigen (PSA), the key biomarker of prostate cancer in human serum. The convincing performance in evaluating the PSA level in serologic tests unambiguously reveals the great potential of our proposed fluorometric and colorimetric dual-channel immunoassay in early clinical diagnosis by monitoring disease biomarkers.
...
PMID:Alkaline Phosphatase-Triggered in Situ Formation of Silicon-Containing Nanoparticles for a Fluorometric and Colorimetric Dual-Channel Immunoassay. 3209 79
<< Previous
1
2
3